GLP-1 medications are gaining popularity for weight management and Type 2 diabetes.The rising costs of GLP-1 medications pose a challenge for self-insured employers.Quantum Health proposes a new model for managing GLP-1 therapy through readiness assessments and targeted support.The webinar discusses balancing cost control with member outcomes in the evolving market and graduating members to lower-cost strategies.